Identification of synthetic compounds active against VRE: the role of the lipidated aminoglucose and the structure of glycopeptide binding pocket

Bioorganic & Medicinal Chemistry Letters
2005.0

Abstract

A modified vancomycin binding pocket (D-O-E ring) incorporating an alpha-hydroxy-beta-amino acid at the AA4 position is designed and synthesized. Some of these compounds display potent bioactivities against both sensitive- and resistant-strains (8 microg/ml against VREF). Both the lipidated aminoglucose and the structure of the 16-membered macrocycle are found to be important for the anti-VRE activities. The polyamine appendage at the C-terminal, on the other hand, improved the activity against vancomycin-sensitive strains.

Knowledge Graph

Similar Paper

Identification of synthetic compounds active against VRE: the role of the lipidated aminoglucose and the structure of glycopeptide binding pocket
Bioorganic & Medicinal Chemistry Letters 2005.0
Design and synthesis of macrocycles active against vancomycin-resistant enterococci (VRE): the interplay between d-Ala-d-Lac binding and hydrophobic effect
Bioorganic & Medicinal Chemistry Letters 2005.0
Design and synthesis of new vancomycin derivatives
Bioorganic & Medicinal Chemistry Letters 2014.0
Synthesis and evaluation of vancomycin and vancomycin aglycon analogues that bear modifications in the residue 3 asparagine
Bioorganic & Medicinal Chemistry Letters 2002.0
Lipophilic vancomycin aglycon dimer with high activity against vancomycin-resistant bacteria
Bioorganic & Medicinal Chemistry Letters 2015.0
Synthesis and Evaluation of Vancomycin Aglycon Analogues That Bear Modifications in the N-Terminal <scp>d</scp>-Leucyl Amino Acid
Journal of Medicinal Chemistry 2009.0
Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci
Journal of Medicinal Chemistry 2018.0
Vancomycin disulfide derivatives as antibacterial agents
Bioorganic &amp; Medicinal Chemistry Letters 2004.0
Mode of Action of Van-M-02, a Novel Glycopeptide Inhibitor of Peptidoglycan Synthesis, in Vancomycin-Resistant Bacteria
Antimicrobial Agents and Chemotherapy 2010.0
Role of the Glycopeptide Framework in the Antibacterial Activity of Hydrophobic Derivatives of Glycopeptide Antibiotics
Journal of Medicinal Chemistry 2003.0